Clinical Trial Detail

NCT ID NCT02673398
Title Neratinib in Treating Older Patients With Locally Advanced or Metastatic HER2-Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors City of Hope Medical Center
Indications

Her2-receptor positive breast cancer

breast cancer

Therapies

Neratinib

Age Groups: adult senior

Additional content available in CKB BOOST